Covered recipient · General Payments record
EMILY J DROUIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2025
$556.85
- Reported across 25 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.61 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $124.61 | 6 |
| Novo Nordisk AS | $101.75 | 3 |
| Astellas Pharma US Inc | $84.30 | 3 |
| Abbott Laboratories | $40.66 | 2 |
| Exact Sciences Corporation | $25.31 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.30 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240919005 | CMS |
| Abbott Laboratories | $22.36 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240938766 | CMS |
| ABBVIE INC. | $23.32 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203601012 | CMS |
| ABBVIE INC. | $18.92 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203601018 | CMS |
| ABBVIE INC. | $22.26 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203601024 | CMS |
| ABBVIE INC. | $20.76 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203601030 | CMS |
| ABBVIE INC. | $24.94 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203601037 | CMS |
| ABBVIE INC. | $14.41 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203601042 | CMS |
| Astellas Pharma US Inc | $29.04 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238677851 | CMS |
| Astellas Pharma US Inc | $22.59 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238572401 | CMS |
| Astellas Pharma US Inc | $32.67 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238627459 | CMS |
| Exact Sciences Corporation | $25.31 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235218897 | CMS |
| Novo Nordisk Inc | $33.93 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188939237 | CMS |
| Novo Nordisk Inc | $34.39 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188878564 | CMS |
| Novo Nordisk Inc | $33.43 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188631765 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.98 | 06/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227673067 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.